News
Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...
ECMO use in cystic fibrosis with severe respiratory failure showed limited survival, highlighting the need for cautious ...
4d
GlobalData on MSNVertex wins European approval for Alyftrek, bolstering cystic fibrosis strongholdWith its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...
The small molecule CFTR modulators market targets cystic fibrosis treatment, driven by innovative therapies, rising prevalence ...
3hon MSN
This shift follows the announcement of initial positive data from the Phase 1/2 clinical trial of PM359 in Chronic ...
3d
Zacks.com on MSNVertex Gets EU Nod for New Cystic Fibrosis Drug AlyftrekVRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years ...
Passage of the bill — which cuts critical health coverage for people with cystic fibrosis and their families — shows the ...
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® ...
Two brothers and two friends take on and wi, an 80-mile Atlantic paddleboard challenge in an effort to provide support for ...
Most children with CF treated at a San Francisco CF clinic did not receive CF liver disease screening in accordance with current guidelines.
10h
The Punch on MSNMale infertilityMale infertility is a complex medical condition that affects millions of couples worldwide. Infertility is defined as the ...
While most of us are familiar with type 1, type 2, and even gestational diabetes, there are actually six kinds of diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results